BRD4 and acute lymphoblastic leukemia: ChIP-seq analysis showed a modest increase in BRD4 binding at transcriptional start sites (TSS) but largely unchanged binding across, gene bodies, and transcriptional end sites (TES) in CHMP5-depleted T-ALL cells (Figures S3A and S3B).